Af­ter Phase 3 de­pres­sion set­back, Neumo­ra paus­es two tri­als to make changes, scraps an­oth­er

Brain health biotech Neumo­ra has stopped two of its Phase 3 tri­als in ma­jor de­pres­sive dis­or­der to make ad­just­ments af­ter the first late-stage study un­ex­pect­ed­ly …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER